Contact
searchSearch
HMP Global

Advertisement

Schizophrenia Learning Library

Featured

quiz
Expert Insights Quiz
What is most important when matching antipsychotic interventions to clinical factors for a patient?
08/08/2024
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN,...
08/08/2024
Psych Congress NP Institute
Amber Hoberg
APP Perspectives
Matching Interventions and Goals in Antipsychotic Treatment for Patient-Centered Care
07/22/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN,...
07/22/2024
Psych Congress NP Institute
quiz
Quiz
Are there FDA-approved LAIs for patients under 18 years with schizophrenia?
07/19/2024
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there...
07/19/2024
Psych Congress NP Institute
Desiree Matthews
Clinical Pearls
Achieving Therapeutic Plasma Concentration Levels With Oral Overlap, IM Loading Doses When Administering LAIs
07/19/2024
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the...
07/19/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
Tolerability Testing LAIs for Schizophrenia Treatment
07/15/2024
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not...
07/15/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Rapid Refresh

Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Julie Carbray
Rapid Refresh
Screening Tools for Adult and Pediatric ADHD
07/26/2024
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
07/26/2024
Psych Congress NP Institute
andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
amber and brooke
Rapid Refresh
Comparing MDD With Mixed Features and Bipolar I Disorder
04/10/2024
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke Kemf answer the audience-posed question, "What are the differences between major depressive disorder (MDD) with mixed features and bipolar I disorder?"
Amber Hoberg, NP, and Brooke...
04/10/2024
Psych Congress NP Institute

Clinical Pearls

Desiree Matthews
Clinical Pearls
Achieving Therapeutic Plasma Concentration Levels With Oral Overlap, IM Loading Doses When Administering LAIs
07/19/2024
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the...
07/19/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute
Andrew Penn
Clinical Pearls
Navigating the Cost, Challenges, and Complexities of Ketamine for Depression Treatment
08/08/2024
Andrew Penn, MS, PMHNP, discusses the evolving questions around ketamine for depression including redosing, financial implications, and pragmatic considerations.
Andrew Penn, MS, PMHNP, discusses the evolving questions around ketamine for depression including redosing, financial implications, and pragmatic considerations.
Andrew Penn, MS,...
08/08/2024
Psych Congress NP Institute
Desiree Matthews
Clinical Pearls
Achieving Therapeutic Plasma Concentration Levels With Oral Overlap, IM Loading Doses When Administering LAIs
07/19/2024
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Gain insights into the...
07/19/2024
Psych Congress NP Institute
Brooke Kempf
Clinical Pearls
When to Consider Adjunctive Treatments for Depression
04/03/2024
Brooke Kempf, MSN, PMHNP-BC, offers her thoughts on how to approach the nuanced decision-making process of augmenting antidepressants.
Brooke Kempf, MSN, PMHNP-BC, offers her thoughts on how to approach the nuanced decision-making process of augmenting antidepressants.
Brooke Kempf, MSN, PMHNP-BC,...
04/03/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Perspectives

Amber Hoberg
APP Perspectives
Matching Interventions and Goals in Antipsychotic Treatment for Patient-Centered Care
07/22/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN,...
07/22/2024
Psych Congress NP Institute
Amber Hoberg
APP Perspectives
Matching Interventions and Goals in Antipsychotic Treatment for Patient-Centered Care
07/22/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses why matching interventions and clinical factors to patients' needs is key to successful treatment with antipsychotics. Learn how to prioritize the patient's goals and tailor your approach.
Amber Hoberg, MSN, APRN,...
07/22/2024
Psych Congress NP Institute
Penn and Jain
Videos
Healing Health Care Burnout and Lessons Learned From the COVID-19 Pandemic
04/16/2024

Featuring Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP

Featuring Saundra Jain, MA, PsyD, LPC...
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and...
04/16/2024
Psych Congress Network
Nurse Mukerji
APP Perspectives
Barriers to Perinatal Mental Health Care: Meeting Patients Where They Are
03/22/2024

With Moushumi Mukerji, PMHNP-BC, CNM

With Moushumi Mukerji, PMHNP-BC, CNM ...
Nurse Mukerji sheds light on the common mood and anxiety disorders experienced during pregnancy and postpartum, navigating stigma, addressing barriers to care, and how health care providers can meet patients where they are. 
Nurse Mukerji sheds light on the common mood and anxiety disorders experienced during pregnancy and postpartum, navigating stigma, addressing barriers to care, and how health care providers can meet patients where they are. 
Nurse Mukerji sheds light on the...
03/22/2024
Psych Congress NP Institute

Expert Insights Quizzes

quiz
Expert Insights Quiz
What is most important when matching antipsychotic interventions to clinical factors for a patient?
08/08/2024
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN,...
08/08/2024
Psych Congress NP Institute
quiz
Quiz
Are there FDA-approved LAIs for patients under 18 years with schizophrenia?
07/19/2024
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there...
07/19/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
Tolerability Testing LAIs for Schizophrenia Treatment
07/15/2024
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not...
07/15/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
What is most important when matching antipsychotic interventions to clinical factors for a patient?
08/08/2024
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN, APRN, PMHNP-BC, when matching antipsychotic interventions to clinical factors for a patient, what is the most important consideration?
According to Amber Hoberg, MSN,...
08/08/2024
Psych Congress NP Institute
An illustration of a pencil marking answers on a quiz sheet.
Quiz
Which ADHD screening tools can be found online?
07/30/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
07/30/2024
Psych Congress NP Institute
quiz
Quiz
Are there FDA-approved LAIs for patients under 18 years with schizophrenia?
07/19/2024
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
True or False: Currently, there...
07/19/2024
Psych Congress NP Institute
quiz
Expert Insights Quiz
Tolerability Testing LAIs for Schizophrenia Treatment
07/15/2024
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not need to test for tolerability before implementing a long-acting injectable into schizophrenia treatment. Take the quiz!
True or False: Clinicians do not...
07/15/2024
Psych Congress NP Institute
Why are clinicians wary of antipsychotic use in MDD treatment?
Expert Insights Quiz
Why do clinicians tend to underuse antipsychotics in the treatment of MDD?
07/27/2023

With Craig Chepke, MD, DFAPA

With Craig Chepke, MD, DFAPA
Time for a pop quiz!
Time for a pop quiz!
Time for a pop quiz!
07/27/2023
Psych Congress Network

Advertisement

Psych NP Institute

 

Nurse Practitioners are at the heart of today's health care system. With the increased need for mental health and psychiatric services, you need in-depth education tailored to your practice in order to provide the best possible care to all patients. The Psych Congress NP Institute event is an essential educational experience, crafted by the world-class leaders of Psych Congress.

Discover this newly available offering that will take a deep dive into everything you need to know about psychopharmacology but have been afraid to ask, including basic psychopharmacology principles and terminology on treatment, disease states, and medication types.

REGISTER NOW

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use